You are here


Hyphens Pharma International eyes Catalist listing

IPO will comprise a cornerstone offering as well as a placement and a public offering


HYPHENS Pharma International is seeking a listing on the Catalist board of the Singapore Exchange, with part of the proceeds from the inital public offering (IPO) to go towards expansion.

The pharmaceutical and consumer healthcare group's core business segments include...

Market voices on: